The effect of multidrug-resistance 1 gene versus neotransduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells
- 15 March 2001
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 97 (6) , 1888-1891
- https://doi.org/10.1182/blood.v97.6.1888
Abstract
Transduction of murine stem cells with a multidrug-resistance 1 gene (MDR1) retrovirus results in dramatic ex vivo and in vivo expansion of repopulating cells accompanied by a myeloproliferative disorder. Given the use ofMDR1-containing vectors in human trials, investigations have been extended to nonhuman primates. Peripheral blood stem cells from 2 rhesus monkeys were collected, CD34-enriched, split into 2 portions, and transduced with eitherMDR1 vectors or neo vectors and continued in culture for a total of 10 days before reinfusion. At engraftment, the copy number in granulocytes was extremely high from bothMDR vectors and neo vectors, but the copy number fell to 0.01 to 0.05 for both. There were no perturbations of the leukocyte count or differential noted. After 3 cycles of stem cell factor/granulocyte colony-stimulating factor, there were no changes in the levels of MDR1 vector– or neovector–containing cells. There was no evidence for expansion ofMDR1 vector–transduced cells. Long-term engraftment with MDR1 vector– and neo vector–transduced cells occurred despite prolonged culture.Keywords
This publication has 14 references indexed in Scilit:
- Prolonged High-Level Detection of Retrovirally Marked Hematopoietic Cells in Nonhuman Primates after Transduction of CD34+ Progenitors Using Clinically Feasible MethodsMolecular Therapy, 2000
- Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer ChemotherapyBlood, 1999
- Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: Are We There Yet?Journal of Hematotherapy, 1999
- Transduction of Murine Bone Marrow Cells With an MDR1 Vector Enables Ex Vivo Stem Cell Expansion, but These Expanded Grafts Cause a Myeloproliferative Syndrome in Transplanted MiceBlood, 1998
- Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating AbilityBlood, 1998
- Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.Journal of Clinical Oncology, 1998
- Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyProceedings of the National Academy of Sciences, 1996
- Gene Transfer into Hematopoietic Stem Cells of Nonhuman PrimatesHuman Gene Therapy, 1996
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Antigen CD34+ marrow cells engraft lethally irradiated baboons.Journal of Clinical Investigation, 1988